Literature DB >> 1606619

A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein.

K Udaka1, T J Tsomides, H N Eisen.   

Abstract

The antigenic structures that initiate T cell responses to foreign (allogeneic) cells have long attracted considerable interest. We have purified and sequenced a peptide from mouse spleen that is recognized in association with the class I MHC protein H-2Ld by 2C, an alloreactive CD8+ T cell clone. The peptide (LSP-FPFDL) greatly enhances the susceptibility of Ld+ cells to lysis by 2C, and this activity is completely blocked by a clonotypic antibody against the 2C T cell receptor. Thus, this study characterizes the naturally occurring peptide moiety of an MHC-I/peptide complex recognized by alloreactive CD8+ T cells. The peptide, which occurs in the thymus of MHC-disparate mice, can be used to study T cell development in mice expressing transgenes for the 2C T cell receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1606619     DOI: 10.1016/0092-8674(92)90617-l

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  67 in total

1.  Competition for self-peptide-MHC complexes and cytokines between naive and memory CD8+ T cells expressing the same or different T cell receptors.

Authors:  Qing Ge; Ailin Bai; Brendan Jones; Herman N Eisen; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

2.  T cell receptor interactions with class I heavy-chain influence T cell selection.

Authors:  S T Kuhns; M D Tallquist; A J Johnson; Y Mendez-Fernandez; L R Pease
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.

Authors:  Susan E Brophy; Lindsay L Jones; Phillip D Holler; David M Kranz
Journal:  Mol Immunol       Date:  2006-12-12       Impact factor: 4.407

Review 4.  Polyspecificity of T cell and B cell receptor recognition.

Authors:  Kai W Wucherpfennig; Paul M Allen; Franco Celada; Irun R Cohen; Rob De Boer; K Christopher Garcia; Byron Goldstein; Ralph Greenspan; David Hafler; Philip Hodgkin; Erik S Huseby; David C Krakauer; David Nemazee; Alan S Perelson; Clemencia Pinilla; Roland K Strong; Eli E Sercarz
Journal:  Semin Immunol       Date:  2007-03-29       Impact factor: 11.130

5.  Analysis of a naturally occurring HLA class I-restricted viral epitope.

Authors:  K Falk; O Rötzschke; S Stevanović; V Gnau; K Sparbier; G Jung; H G Rammensee; P Walden
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

6.  Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells.

Authors:  R A Henderson; A L Cox; K Sakaguchi; E Appella; J Shabanowitz; D F Hunt; V H Engelhard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor.

Authors:  R Brock; K H Wiesmüller; G Jung; P Walden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

8.  Japanese encephalitis virus infection of mouse cell lines: ability to prime mice for generation of virus specific cytotoxic T lymphocytes and differences in CTL recognisable viral determinants.

Authors:  K Murali-Krishna; V Ravi; R Manjunath
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

9.  A mutation in the alpha 3 domain of Db that abrogates CD8 binding does not affect presentation of an immunodominant H-Y peptide.

Authors:  J P Dutz; S J Teh; N Killeen; H S Teh
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

10.  Resting and activated T cells display different requirements for CD8 molecules.

Authors:  Z Cai; J Sprent
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.